Skip to content

Nasdaq · CIK 0000714256

SMTI Sanara MedTech Inc.

Insider trading from SEC Form 4. Last filing 29 d ago.

In brief

Sanara MedTech Inc. (SMTI) has 44 SEC Form 4 filings on file from 14 insiders, the latest filed on Sep 16, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company

Signals

Open-market buys and sells at Sanara MedTech Inc., scored.

No scored open-market trades yet. Grants, exercises and other rows are below.

Transactions

Every row filed, 49 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Sep 15, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-3,661$35.11$129k105,88529 d ago
Jun 4, 2026Robert Andrew DeSutter
director
AGrant or award
Common Stock
+5,539$0.00$028,740Jun 5, 2026
Jun 4, 2026Eric D Tanzberger
director
AGrant or award
Common Stock
+5,308$0.00$022,966Jun 5, 2026
Jun 4, 2026Ann Beal Salamone
director
AGrant or award
Common Stock
+4,154$0.00$026,858Jun 5, 2026
Jun 4, 2026Sara N Ortwein
director
AGrant or award
Common Stock
+4,616$0.00$025,415Jun 5, 2026
Jun 4, 2026Keith G Myers
director
AGrant or award
Common Stock
+4,385$0.00$09,325Jun 5, 2026
Jun 4, 2026Eric D Major
director
AGrant or award
Common Stock
+4,846$0.00$014,232Jun 5, 2026
Jun 4, 2026Roszell Mack III
director
AGrant or award
Common Stock
+5,308$0.00$021,842Jun 5, 2026
Jun 4, 2026Ronald T Nixon
director, owner
AGrant or award
Common Stock
+4,154$0.00$068,196Jun 5, 2026
May 15, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-3,852$21.06$81k109,546May 18, 2026
Mar 22, 2026Ashley M Mackey
Controller
AGrant or award
Common Stock
+2,804$0.00$04,967May 5, 2026
Apr 15, 2026Jacob A. Waldrop
Chief Operating Officer
FTax withholding
Common Stock
-378$20.01$7,56424,377Apr 16, 2026
Mar 22, 2026Ashley M Mackey
Controller
AGrant or award
Common Stock
-2,804$0.00$05,067Mar 23, 2026
Mar 22, 2026Seth D Yon
Chief Executive Officer
AGrant or award
Common Stock
-25,430$0.00$0113,398Mar 23, 2026
Mar 22, 2026Elizabeth B Taylor
Chief Financial Officer
AGrant or award
Common Stock
-12,687$0.00$017,632Mar 23, 2026
Mar 22, 2026Jacob A. Waldrop
Chief Operating Officer
AGrant or award
Common Stock
-13,956$0.00$024,755Mar 23, 2026
Mar 7, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-596$18.87$11k87,968Mar 10, 2026
Mar 1, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-414$20.44$8,46288,564Mar 9, 2026
Mar 1, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-491$20.44$10k88,487Mar 2, 2026
Feb 25, 2026Ashley M Mackey
Controller
FTax withholding
Common Stock
-149$19.90$2,9652,263Feb 27, 2026
Feb 25, 2026Elizabeth B Taylor
Chief Financial Officer
FTax withholding
Common Stock
-437$19.90$8,6964,945Feb 27, 2026
Feb 25, 2026Jacob A. Waldrop
Chief Operating Officer
FTax withholding
Common Stock
-714$19.90$14k10,799Feb 27, 2026
Feb 25, 2026Seth D Yon
Chief Executive Officer
FTax withholding
Common Stock
-873$19.90$17k88,978Feb 27, 2026
Sep 15, 2025Seth D Yon
Chief Executive Officer
AGrant or award
Common Stock
+28,563$0.00$089,851Sep 16, 2025
Aug 19, 2025Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
FTax withholding
Common Stock
-2,324$30.86$72k28,587Aug 19, 2025
May 22, 2025Eric D Tanzberger
director
AGrant or award
Common Stock
+3,590$0.00$017,658May 28, 2025
May 22, 2025Roszell Mack III
director
AGrant or award
Common Stock
+3,433$0.00$016,534May 27, 2025
May 22, 2025Eric D Major
director
AGrant or award
Common Stock
+3,277$0.00$09,386May 27, 2025
May 22, 2025Keith G Myers
director
AGrant or award
Common Stock
+2,965$0.00$04,940May 27, 2025
May 22, 2025Sara N Ortwein
director
AGrant or award
Common Stock
+3,277$0.00$020,799May 27, 2025
May 22, 2025Ann Beal Salamone
director
AGrant or award
Common Stock
+2,809$0.00$022,704May 27, 2025
May 22, 2025Robert Andrew DeSutter
director
AGrant or award
Common Stock
+3,746$0.00$023,201May 27, 2025
May 15, 2025Seth D Yon
Pres. & Ch. Commercial Officer
FTax withholding
Common Stock
-4,929$30.88$152k61,288May 16, 2025
Apr 15, 2025Jacob A. Waldrop
Chief Operating Officer
FTax withholding
Common Stock
-378$29.38$11k11,513Apr 17, 2025
Apr 10, 2025Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
FTax withholding
Common Stock
-527$34.69$18k31,994Apr 11, 2025
Apr 10, 2025Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
FTax withholding
Common Stock
-343$34.69$12k31,651Apr 11, 2025
Apr 10, 2025Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
FTax withholding
Common Stock
-378$33.01$12k31,273Apr 11, 2025
Apr 10, 2025Michael D. McNeil
Ch. Acct. & Ch. Admin. Officer
FTax withholding
Common Stock
-362$34.65$13k30,911Apr 11, 2025
Nov 11, 2024Keith G Myers
director
AGrant or award
Common Stock
+1,975$0.00$01,975Nov 13, 2024
Jun 12, 2024Robert Andrew DeSutter
director
AGrant or award
Common Stock
+3,932$0.00$019,455Jun 14, 2024
Mar 7, 2024Zachary B. Fleming
Chief Executive Officer
AGrant or award
Common Stock
+12,693$0.00$048,854Mar 11, 2024
Mar 7, 2024Michael D. McNeil
Chief Financial Officer
AGrant or award
Common Stock
+4,650$0.00$025,998Mar 11, 2024
Mar 1, 2024Zachary B. Fleming
Chief Executive Officer
FTax withholding
Common Stock
-926$38.96$36k36,951Mar 5, 2024
Mar 1, 2024Michael D. McNeil
Chief Financial Officer
FTax withholding
Common Stock
-687$38.96$27k21,947Mar 5, 2024
Mar 1, 2024Zachary B. Fleming
Chief Executive Officer
FTax withholding
Common Stock
-790$38.96$31k36,161Mar 5, 2024
Mar 1, 2024Michael D. McNeil
Chief Financial Officer
FTax withholding
Common Stock
-599$38.96$23k21,348Mar 5, 2024
Feb 1, 2024Zachary B. Fleming
Chief Executive Officer
FTax withholding
Common Stock
-427$33.72$14k37,877Feb 5, 2024
Feb 1, 2024Michael D. McNeil
Chief Financial Officer
FTax withholding
Common Stock
-391$33.72$13k22,634Feb 5, 2024
Jan 1, 2024Zachary B. Fleming
Chief Executive Officer
FTax withholding
Common Stock
-1,255$41.10$52k38,304Jan 3, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about SMTI

Answered from the filings on this page, as of the latest one.

Are insiders buying SMTI?

No. In the last 90 days no insider at Sanara MedTech Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade SMTI on the open market?

No open-market trade has been scored at Sanara MedTech Inc.. The latest Form 4 on file was filed on Sep 16, 2026 and holds grants, exercises or other rows that are not market trades.

How many insiders file Form 4 at Sanara MedTech Inc.?

14 people have filed a Form 4 at Sanara MedTech Inc., among them Robert Andrew DeSutter (director), Zachary B. Fleming (Chief Executive Officer), Roszell Mack III (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.